Name Jung-Min Ahn
Country Korea (South)
Job Interventional Cardiologist

Other content(s) by This Operator

  1. Does the Timing of IABP Matter?
  2. FFR Guided Functional Angioplasty
  3. Two Cases with Coronary Thromboembolism
  4. FFR-guided PCI in Tandem Lesion
  5. Long Lesion and Tandem Lesion
  6. Promus Element Clinical Program in Asan Medical Center
  7. FFR Utilization in LM PCI
  8. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  9. Novice's Trial of Complex LM PCI
  10. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  11. Case Presentation: Functional Angioplasty
  12. Anatomical - Functional Stenosis: How Much Discordant?
  13. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  14. Cross and Perfect: 2013 Update
  15. IRIS-ELEMENT Data Review
  16. LM PCI
  17. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  18. VH IVUS: Native Plaque and Neointima
  19. LM & Tandem Lesion
  20. Case-based Review: Incidence and Treatment of LM ISR
  21. Clinical Implementation of FFR
  22. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  23. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  24. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  25. TAVI for Bicuspid Valve Stenosis
  26. Understanding About Visual-Functional Mismatching
  27. Left Main PCI
  28. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  29. Preliminary Data from IRIS FFR Registry
  30. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  31. Readmission After PCI or CABG
  32. TAVR for Bicuspid AV: Tips and Tricks
  33. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  34. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  35. Final Answer RESTORE
  36. Self-Expandable Evolut R & PRO Valve
  37. TAVR for Bicuspid AV: Tips and Tricks
  38. Left Main
  39. Integrated Use of IVUS and FFR in Real Practice
  40. Tandem Lesion Evaluation
  41. [Review in 2015] Physiology
  42. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  43. Elderly Population
  44. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  45. Practical Aspect of IMR in AMI and Stable Angina
  46. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  47. Bicuspid TAVR Registry
  48. Tandem
  49. Clinical Impact of Routine FFR Measurement
  50. Current Status of TAVR: High/Intermediate and Lower Risk
  51. AP TAVR Registry
  52. Utility of Intravascular Imaging for Resolving Issues During PCI
  53. Left Main and MVD PCI: Imaging and Functional Guidance
  54. Clinical Outcome of DEFER
  55. Bicuspid and Valve-in-Valve; How Different?
  56. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  57. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  58. Integrated Use of FFR and IVUS for LM PCI
  59. Bicuspid AS: Future Perspectives of TAVR
  60. [Taped Case] TAVR with Evolut R
  61. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  62. Asian Pacific TAVR Registry
  63. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  64. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  65. FFR as the Gold Standard Index!
  66. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  67. Distal Left Main Bifurcation PCI: Concept Is More Important.
  68. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  69. How About Integrated Use of Resting Pd/Pa and FFR?
  70. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  71. Expert Case Review: Complex Bifurcation PCI
  72. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  73. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  74. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  75. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  76. Current Status of Balloon-Expandable TAVR in Korea
  77. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  78. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  79. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  80. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  81. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  82. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  83. Bifurcation PCI: Contemporary Practical Approach
  84. Post TAVR Coronary Access with Evolut System
  85. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  86. How to Treat Tandem Lesion Under Physiology-Guidance
  87. Imaging-guided PSP for Optimizing PCI
  88. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection